Osamu Irie
Osamu Irie, Tsukuba JP
Patent application number | Description | Published |
---|---|---|
20080319018 | ORGANIC COMPOUNDS - The present invention relates to a compound of the formula I | 12-25-2008 |
20090186889 | SPIRO-SUBSTITUTED PYRROLOPYRIMIDINES - The invention provides compounds of formula I or a pharmaceutically acceptable salt or ester thereof formula I | 07-23-2009 |
20100160305 | 3, 4, 5 - Substituted Piperidine Compounds - 3,4,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4,5-substituted piperidine compound, a method for the manufacture of a 3,4,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. | 06-24-2010 |
20130005770 | ORGANIC COMPOUNDS - The present invention relates to a compound of the formula I | 01-03-2013 |
Osamu Irie, Ibaraki JP
Patent application number | Description | Published |
---|---|---|
20090048230 | COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS - The present invention relates to the use of a 2-cyanopyrimidine compound of the formula | 02-19-2009 |
20090192148 | Organic Compounds - The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. | 07-30-2009 |
20100029647 | 3,4,(5)-SUBSTITUTED TETRAHYDROPHYRIDINES - 3,4(,5)-substituted tetrahydropyridine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4(,5)-substituted tetrahydropyridine compound, and/or a method of treatment comprising administering a 3,4(,5)-substituted tetrahydropyridine compound, a method for the manufacture of a 3,4(,5)-substituted tetrahydropyridine compound, and novel intermediates and partial steps for its synthesis. | 02-04-2010 |
Osamu Irie, Ibaraki Pref. JP
Patent application number | Description | Published |
---|---|---|
20090054467 | Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases - The invention provides compounds of Formula I or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors. | 02-26-2009 |